Is WGS or XGN more undervalued in 2026?

CirclFi compares GeneDx Holdings Corp. (WGS) and Exagen Inc. (XGN) using 13 institutional-grade valuation models. WGS has a Quality of Company score of 6.0/10 while XGN scores 6.3/10.

Which is a better buy — WGS or XGN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do WGS and XGN valuations compare?

WGS at $50.15 and XGN at $5.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

WGS vs XGN Valuation Comparison 2026 — Intrinsic Value Analysis

WGS

Diagnostics & Research

GeneDx Holdings Corp.

Quality

6.0

out of 10

Value Trap

SAFE

Price

$50.15

Last close

Models

12/13

Active

XGN

Diagnostics & Research

Exagen Inc.

Quality

6.3

out of 10

Value Trap

SAFE

Price

$5.08

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	WGS Fair Value	WGS Upside	XGN Fair Value	XGN Upside
Bayesian DCF	Intrinsic	$7.40	-85.2%	$1.40	-72.5%
Earnings Power Value	Intrinsic	$2.79	-95.7%	$4.38	+43.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for WGS vs XGN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

WGS vs XGN — Which Stock Is More Undervalued?

XGN scores higher with a 6.3/10 quality rating vs WGS's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing GeneDx Holdings Corp. (WGS) and Exagen Inc. (XGN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

WGS currently trades at $50.15 with a QOC of 6.0/10, while XGN trades at $5.08 with a QOC of 6.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).